Hepatitis C virus (HCV; a plus-stranded RNA virus) is recognized to the family Flaviviridae, infected > 200 million people worldwide (Waheed et al., 2009), and caused death in greater than 350,000 during 2012 (World Health Organization, 2012). 20% of acute viral hepatitis and 50% of chronic viral hepatitis (Alter et al., 1992; Kumar et al., 2005) can increase the risk of liver cirrhosis and hepatocellular carcinoma in about more than 170 million patients (World Health Organization, 1997; Kabbaj et al., 2006; Matsumori et al., 2010). The prevalence of HCV differs from area to area and there are 6 genotypes for HCV on the basis of nucleotides sequence divergence (Safi et al., 2010; Waheed, 2015). In pregnant women, the range of anti-hepatitis C virus (HCV) was from 0.7% to 4.4% (Hillemanns et al., 1998; Resti et al., 1998) and the rate of viremia was from 63% to 69% (Granovsky et al., 1998; Conte et al., 2000).